- Home
- PRGO vs NVG Comparison
PRGO vs NVG Comparison
Compare PRGO & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- NVG
- Stock Information
- Founded
- PRGO 1887
- NVG 1999
- Country
- PRGO Ireland
- NVG United States
- Employees
- PRGO N/A
- NVG N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- PRGO Health Care
- NVG Finance
- Exchange
- PRGO Nasdaq
- NVG Nasdaq
- Market Cap
- PRGO 3.1B
- NVG 2.6B
- IPO Year
- PRGO 1991
- NVG N/A
- Fundamental
- Price
- PRGO $21.48
- NVG $12.50
- Analyst Decision
- PRGO Buy
- NVG
- Analyst Count
- PRGO 3
- NVG 0
- Target Price
- PRGO $34.00
- NVG N/A
- AVG Volume (30 Days)
- PRGO 1.5M
- NVG 568.8K
- Earning Date
- PRGO 11-05-2025
- NVG 01-01-0001
- Dividend Yield
- PRGO 5.41%
- NVG 4.65%
- EPS Growth
- PRGO N/A
- NVG N/A
- EPS
- PRGO N/A
- NVG N/A
- Revenue
- PRGO $4,326,100,000.00
- NVG N/A
- Revenue This Year
- PRGO $2.23
- NVG N/A
- Revenue Next Year
- PRGO $0.54
- NVG N/A
- P/E Ratio
- PRGO N/A
- NVG N/A
- Revenue Growth
- PRGO N/A
- NVG N/A
- 52 Week Low
- PRGO $20.52
- NVG $9.68
- 52 Week High
- PRGO $30.93
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- PRGO 43.91
- NVG 64.19
- Support Level
- PRGO $21.30
- NVG $12.39
- Resistance Level
- PRGO $22.02
- NVG $12.44
- Average True Range (ATR)
- PRGO 0.52
- NVG 0.08
- MACD
- PRGO 0.07
- NVG -0.01
- Stochastic Oscillator
- PRGO 50.17
- NVG 78.57
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.